RecruitingNCT06137313
Exposure to Hepatitis E Virus in Occitania, France
Determination of HEV Seroprevalence Among Blood Donors in Occitania
Sponsor
University Hospital, Toulouse
Enrollment
5,000 participants
Start Date
Dec 15, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of the proposed work is to determine the seroprevalence of HEV in 2023 in a population of blood donors living in Occitania. Compare the current frequency of anti-HEV IgG and IgM markers with that of 2011. The serological techniques used and the questionnaires will be similar
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Inclusion Criteria1
- blood donors
Exclusion Criteria1
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERquestionnaire
completion of a questionnaire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06137313